Does Insurance Cover Peptide Therapy?

Key Takeaways

Most insurance plans do not cover peptide therapy because it’s classified as wellness, anti-aging, or performance optimization rather than medically necessary treatment
The major exception is FDA-approved GLP-1 peptides like semaglutide and tirzepatide, which many insurers now cover for weight loss and diabetes
You can reduce out-of-pocket costs through HSA/FSA accounts, compounding pharmacy pricing, telehealth providers, and superbill reimbursement
Monthly peptide therapy costs range from $150-$500+ depending on the peptide, provider, and protocol

The Short Answer
Why Most Insurance Doesn’t Cover Peptide Therapy
Peptides That Insurance May Cover
Peptides That Insurance Won’t Cover
How to Check Your Coverage
Using HSA and FSA for Peptide Therapy
Superbills and Out-of-Network Reimbursement
What Peptide Therapy Actually Costs Without Insurance
Ways to Lower Your Out-of-Pocket Costs
FAQ
Sources

No, most insurance plans do not cover peptide therapy. The majority of peptides used in regenerative medicine, anti-aging, and performance optimization — including BPC-157, GHK-Cu, CJC-1295/Ipamorelin, and Sermorelin — are considered elective treatments by insurers [1][2].

The reasoning is straightforward from the insurance company’s perspective: these peptides are not FDA-approved for the conditions they’re commonly prescribed for, making them “off-label” or “experimental” in insurance terminology. And insurers generally don’t pay for experimental treatments.

There are exceptions, though. And there are strategies to minimize what you pay out of pocket. Understanding peptide therapy costs and insurance realities upfront will save you frustration later.

Why Most Insurance Doesn’t Cover Peptide Therapy

Insurance coverage decisions come down to three factors, and most peptide therapies fail on all three:

FDA approval status. Most therapeutic peptides used in clinics — BPC-157, TB-500, GHK-Cu, Ipamorelin, CJC-1295 — are not FDA-approved drugs. They’re compounded medications or supplements. Insurance companies rely heavily on FDA approval as their coverage benchmark [1].

Medical necessity classification. Even when a peptide could theoretically help a medical condition, insurers often classify peptide therapy as “wellness” or “optimization” rather than medically necessary treatment. Healing a sports injury faster? That’s enhancement, not necessity, in their view [2].

Lack of large-scale clinical trial data. Insurance formulary committees want randomized controlled trials, systematic reviews, and clinical guidelines from major medical organizations. While peptides like BPC-157 have extensive animal research and growing clinical use, the human trial data that satisfies insurance reviewers is limited [3].

This isn’t unique to peptides. Many areas of regenerative and functional medicine face the same coverage gap. The insurance model was built around treating diagnosed diseases with FDA-approved drugs, not optimizing health or accelerating healing with compounded biologics.

Peptides That Insurance May Cover

Not all peptides are treated equally by insurers. A few have crossed the FDA-approval threshold:

Semaglutide (Ozempic, Wegovy, Rybelsus). This GLP-1 receptor agonist is FDA-approved for both type 2 diabetes and chronic weight management. Many insurance plans now cover it, though prior authorization is almost always required and some plans restrict it to patients with a BMI above 30 (or 27 with comorbidities). Copays can still be significant — $25-$300/month depending on your plan [4].

Tirzepatide (Mounjaro, Zepbound). The dual GIP/GLP-1 agonist has FDA approval for type 2 diabetes (Mounjaro) and weight loss (Zepbound). Coverage is expanding rapidly but varies by insurer. For a comparison of these two, see our semaglutide vs tirzepatide guide.

Growth hormone (Genotropin, Norditropin, etc.). Prescription human growth hormone is covered for diagnosed growth hormone deficiency confirmed by stimulation testing. This is relevant because some patients use growth hormone secretagogues like Sermorelin or Ipamorelin as alternatives — those alternatives are not covered.

Insulin and other diabetes peptides. Insulin is a peptide, and it’s obviously covered. Other diabetes-related peptide drugs (exenatide, liraglutide) also have coverage when prescribed for approved indications.

The pattern is clear: FDA approval plus a specific disease diagnosis equals potential coverage.

Peptides That Insurance Won’t Cover

These are the peptides most commonly used in clinical peptide therapy that insurance consistently refuses:

BPC-157: Used for tissue healing, gut repair, and joint pain. Not FDA-approved. Compounding is now restricted under FDA Category 2 [5]. No insurance coverage.

Sermorelin: A growth hormone-releasing hormone analog used for anti-aging, recovery, and sleep improvement. Although it was previously FDA-approved (as Geref), that approval was withdrawn when the manufacturer discontinued it. Compounded Sermorelin is not covered.

CJC-1295/Ipamorelin: Popular growth hormone secretagogue stack for body composition, recovery, and energy. Not FDA-approved. No coverage.

GHK-Cu: Copper peptide used for skin rejuvenation, hair growth, and tissue repair. Available as topical and injectable. Not covered.

TB-500: Used alongside BPC-157 in the Wolverine stack for recovery. Not FDA-approved, now Category 2. No coverage.

NAD+: Increasingly used for energy, cognitive function, and longevity. Not a peptide technically, but commonly offered at peptide therapy clinics. Not covered by insurance.

How to Check Your Coverage

If you’re hoping your specific situation might be an exception, here’s how to check:

Step 1: Call your insurer directly. Use the number on the back of your insurance card. Ask specifically: “Does my plan cover compounded peptide medications prescribed by a licensed physician?” Have the specific peptide name and the diagnosis code (ICD-10) your doctor would use.

Step 2: Ask about prior authorization. For GLP-1 peptides (semaglutide, tirzepatide), your insurer may cover them with prior authorization. Your prescribing physician submits documentation of medical necessity. This process takes 1-3 weeks typically.

Step 3: Check your plan’s formulary. Most insurers publish their drug formulary online. Search for the specific peptide or brand name. If it’s not listed, it’s not covered.

Step 4: Ask about out-of-network benefits. Some PPO plans provide partial reimbursement for out-of-network providers. Even if the peptide itself isn’t covered, the physician consultation might be partially reimbursable.

Step 5: Request a coverage determination in writing. If your insurer denies coverage verbally, ask for the denial in writing with the specific exclusion cited. This is useful for appeals and for understanding exactly what your plan does and doesn’t cover.

Using HSA and FSA for Peptide Therapy

This is where many patients find real savings. Health Savings Accounts (HSA) and Flexible Spending Accounts (FSA) can often be used for peptide therapy costs, even when insurance won’t cover them [6].

What qualifies: Medical consultations with licensed providers, prescription medications (including compounded prescriptions), lab work ordered by your physician, and medically necessary treatments generally qualify for HSA/FSA spending.

What may not qualify: Over-the-counter supplements (including oral BPC-157 sold as a supplement), cosmetic treatments, and general “wellness” services may not qualify unless prescribed for a specific medical condition.

How to maximize this:

Get a formal diagnosis from your physician (e.g., “tendinopathy” rather than “wants faster recovery”)
Obtain an itemized receipt showing the provider, service, diagnosis code, and amount
Keep your prescription on file — this documents medical necessity
If using an HSA debit card, the charge may go through automatically at a medical provider’s office

Tax advantage: HSA contributions are pre-tax, earnings grow tax-free, and withdrawals for qualified medical expenses are tax-free. At a 30% marginal tax rate, paying $400/month for peptide therapy through your HSA effectively costs you $280 after tax savings.

Superbills and Out-of-Network Reimbursement

A superbill is an itemized receipt from your healthcare provider that includes all the information your insurance company needs to process a reimbursement claim.

What a superbill includes:

Provider’s name, credentials, NPI number, and tax ID
Date of service
Diagnosis codes (ICD-10)
Procedure codes (CPT)
Charges for each service

How to use it: You pay your peptide therapy provider directly, they give you a superbill, and you submit it to your insurance company for out-of-network reimbursement. Your insurer applies it to your deductible and, if applicable, reimburses a percentage.

Realistic expectations: Most patients see reimbursement for the consultation and lab work portions, not the peptide medication itself. If your out-of-network deductible is $3,000 and you spend $2,400/year on peptide therapy consultations, you may not see any reimbursement — but those costs do count toward your deductible, which could matter if you have other medical expenses.

Ask your peptide therapy clinic if they provide superbills. Many telehealth peptide providers include this as a standard offering [2].

What Peptide Therapy Actually Costs Without Insurance

Since most people pay out of pocket, here’s what to budget:

Initial consultation: $99-$300 depending on the provider. Telehealth consultations tend to be at the lower end. In-person visits at a peptide clinic are typically higher.

Lab work: $100-$400 for initial bloodwork. Some providers include basic panels in their consultation fee. Comprehensive panels (hormones, metabolic markers, inflammatory markers) cost more.

Peptide costs by type (monthly):

Peptide	Monthly Cost Range
BPC-157 (oral supplement)	$50-$120
BPC-157 (injectable, where available)	$150-$300
Sermorelin	$150-$300
CJC-1295/Ipamorelin	$200-$400
GHK-Cu (topical)	$40-$100
Semaglutide (compounded)	$150-$350
Tirzepatide (compounded)	$200-$450
NAD+ (subcutaneous)	$200-$500

Supplies: $20-$50/month for syringes, bacteriostatic water, alcohol swabs, and a sharps container if using injectables.

Follow-up visits: $50-$150 each, typically every 4-8 weeks.

Total monthly range: $200-$500 for a single-peptide protocol. Multi-peptide stacks or GLP-1 programs can run $400-$800/month.

For a deeper cost breakdown, see our peptide therapy cost guide and our page on how much peptide therapy costs.

Ways to Lower Your Out-of-Pocket Costs

Choose telehealth over in-person. Online peptide clinics have lower overhead and typically charge less for consultations. Many offer monthly subscription models that bundle the visit, peptides, and follow-ups.

Use a compounding pharmacy instead of brand-name. For peptides that have brand-name equivalents (like semaglutide), compounded versions from a compounding pharmacy can cost 50-80% less. Compounded semaglutide runs $150-$350/month vs $1,000+/month for brand-name Wegovy without insurance.

Ask about multi-month pricing. Many clinics offer discounts for 3-month or 6-month commitments. This can reduce per-month costs by 10-20%.

Use HSA/FSA funds as described above.

Consider oral formulations. For peptides like BPC-157, oral versions are significantly cheaper than injectable forms and don’t require supplies.

Bundle services. Some clinics offer package pricing that includes consultation, labs, peptides, and follow-ups at a lower total cost than purchasing each separately.

Compare providers. Pricing varies dramatically between clinics. A peptide therapy consultation at one clinic might cost $250, while another charges $99 for the same service. The peptide markup is where the biggest variance occurs.

FAQ

Will insurance ever cover peptide therapy?▼

Coverage is expanding for FDA-approved peptides. Semaglutide and tirzepatide went from almost no coverage to widespread coverage in just a few years as obesity gained recognition as a treatable disease. If other peptides eventually receive FDA approval, similar coverage expansion is possible. For now, most therapeutic peptides remain uncovered. The legal and regulatory picture would need to shift significantly first.

Can I use my HSA to pay for BPC-157?▼

If BPC-157 is prescribed by a licensed physician for a diagnosed medical condition, the consultation and prescription costs may qualify for HSA/FSA reimbursement. Over-the-counter BPC-157 supplements purchased without a prescription are less likely to qualify. Keep documentation — your prescription and diagnosis — in case your HSA administrator requests substantiation.

Is peptide therapy tax deductible?▼

Medical expenses exceeding 7.5% of your adjusted gross income are tax-deductible if you itemize. Peptide therapy prescribed by a licensed physician for a medical condition counts as a medical expense. If your AGI is $80,000 and your total medical expenses (including peptide therapy) exceed $6,000, the amount above $6,000 is deductible. Consult a tax professional for your specific situation.

Why is compounded semaglutide so much cheaper than Ozempic?▼

Brand-name Ozempic/Wegovy includes the cost of Novo Nordisk’s clinical trials, marketing, patent protection, and profit margin — leading to list prices of $1,000-$1,600/month. Compounded semaglutide uses the same active ingredient produced by a compounding pharmacy without those overhead costs, resulting in prices of $150-$350/month. The trade-off is that compounded versions are not FDA-approved as finished products, though the compounding process itself is regulated.

Do any peptide clinics accept insurance?▼

A small number of peptide clinics accept insurance for the office visit or consultation portion, billing it as a medical evaluation. The peptide medications themselves are almost never billed through insurance. Most peptide therapy clinics operate on a cash-pay model and provide superbills for you to submit for potential reimbursement. When comparing clinics, ask specifically what’s included in their pricing and whether they provide insurance documentation.

Sources

Prime IV Hydration. “Cost of Peptide Therapy: Beginner’s Guide.” August 2025. primeivhydration.com
Concierge MD LA. “Will Insurance Cover Peptide Therapy?” July 2025. conciergemdla.com
Age Well ATL. “Key Financial Considerations When Choosing a Peptide Therapy Facility.” November 2025. agewellatl.net
The Body Mod. “Insurance Coverage — GLP-1 Peptide Therapy.” 2024. thebodymod.com
FDA. “Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A.” January 2025. FDA.gov
IRS. “Publication 502: Medical and Dental Expenses.” irs.gov
My Peptide Match. “How Much Does Peptide Therapy Cost? A Pricing Breakdown.” February 2026. mypeptidematch.com